Pfizer Looks To Team Up With Shanghai Pharmaceutical To Co-develop And Commercialize Pfizer Products In China
This article was originally published in The Pink Sheet Daily
Executive Summary
The MOU with Pfizer enables the two companies to explore cooperation throughout the whole value chain, including R&D, product registration, commercialization, distribution and even manufacturing, SPH said.